Radiotherapy for head and neck cancer: An increasing dependence on innovative imaging

Onkologie

Volumn 35, Issue 5, 2012, Pages 287-292

  Nuyts, Sandra ^a   Fairchild, Alysa ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

Head and neck cancer; Imaging; MRI; PET; Radiotherapy

Indexed keywords

BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18;

ACCURACY; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; IMAGE GUIDED RADIOTHERAPY; IMAGE RECONSTRUCTION; IMAGING SYSTEM; INNOVATIVE IMAGING; INTENSITY MODULATED RADIATION THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; TREATMENT RESPONSE;

HEAD AND NECK NEOPLASMS; HUMANS; MOLECULAR IMAGING; PROGNOSIS; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, IMAGE-GUIDED; TREATMENT OUTCOME;

EID: 84862075775     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000338433     Document Type: Review

References (31)

1. Licitra L, Felip E for the ESMO Guidelines Working Group: Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009;20(suppl 4):121-122.
2. Bhide S, Kazi R, Newbold K, Harrington K, Nutting C: The role of intensity-modulated radiotherapy in head and neck cancer. Ind J Cancer 2010;47:267-273.
3. Kam M, Leung S, Zee B, Chau R, Suen J, Mo F, Lai M, Ho R, Cheung K, Yu B, Chiu S, Choi P, Teo P, Kwan W, Chan A: Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal cancer patients. J Clin Oncol 2007;25:4873-4879.
4. Pow E, Kwong D, McMillan A, Wong M, Sham J, Leung L, Leung W: Xerostomia and quality of life after intensity-modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006;66:981-991.
5. Nutting C, Morden J, Harrington K, Urbano T, Bhide S, Clark C, Miles E, Miah A, Newbold K, Tanay M, Adab F, Jefferies S, Scrase C, Yap B, A'Hern R, Sydenham M, Emson M, Hall E: Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127-136.
6. Troost E, Schinagl D, Bussink J, Oyen W, Kaanders J: Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours. Radiother Oncol 2010;96:328-334.
7. Hustinx R, Lucignani G: PET/CT in head and neck cancer: An update. Eur J Nucl Med Mol Imaging 2010;37:645-651.
8. Syed R, Bomanji J, Nagabhushan N, Hughes S, Kayani I, Groves A, Gacinovic S, Hydes N, Visvikis D, Copland C, Ell P: Impact of combined 18F-FDG PET/CT in head and neck tumours. Br J Cancer 2005;92:1046-1050.
9. Scarfone C, Lavely W, Cmelak A, Delbeke D, Martin W, Billheimer D, Hallahan D: Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 2004;45:543-552.
10. Koshy M, Paulino A, Howell R, Schuster D, Halkar R, Davis L: F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck 2005;27:494-502.
11. Nishioka T, Shiga T, Shirato H, Tsukamoto E, Tsuchiya K, Kato T, Ohmori K, Yamazaki A, Aoyama H, Hashimoto S, Chang T, Miyasaka K: Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 2002;53:1051-1057.
12. Paulino A, Koshy M, Howell R, Schuster D, Davis L: Comparison of CT-and FDG-PETdefined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005;61:1385-1392.
13. Ling C, Humn J, Larson S, Amols H, Fuks Z, Leibel S, Koutcher J: Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47:551-560.
14. Chapman J, Bradley J, Eary J, Haubner R, Larson S, Michalski J, Okunieff P, Strauss H, Ung Y, Welch M: Molecular (functional) imaging for radiotherapy applications: an RTOG symposium. Int J Radiat Oncol Biol Phys 2003;55:294-301.
15. Bussink J, van Herpen C, Kaanders J, Oyen W: PET-CT for response assessment and treatment adaptation in head and neck cancer. Lancet Oncol 2010;11:661-669.
16. Castadot P, Lee J, Geets X, Gregoire V: Adaptive radiotherapy of head and neck cancer. Semin Radiat Oncol 2010;20:84-93.
17. Barker J, Garden A, Ang K, O'Daniel J, Wang H, Court L, Morrison W, Rosenthal D, Chao K, Tucker S, Mohan R, Dong L: Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 2004;59:960-970.
18. Geets X, Tomsej M, Lee J, Duprez T, Coche E, Cosnard G, Lonneux M, Gregoire V: Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumours: Impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol 2007;85:105-115.
19. Farrag A, Ceulemans G, Voordeckers M, Everaert H, Storme G: Can 18F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients? Nucl Med Commum 2010;31:495-501.
20. Murphy J, La T, Chu K, Quon A, Fischbein N, Maxim P, Graves E, Loo B, Le Q: Postradiation metabolic tumour volume predicts outcome in head and neck cancer. Int J Radiat Oncol Biol Phys 2011;80:514-521.
21. Langerman A, Plein C, Vokes E, Salama J, Haraf D, Blair E, Stenson K: Neck response to chemoradiotherapy: Complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer. Arch Otolar Head Neck Surg 2009;135: 1133-1136.
22. Yao M, Smith R, Hoffman H, Funk G, Lu M, Menda Y, Graham M, Buatti J: Clinical significance of post-radiotherapy FDG-PET imaging in management of head and neck cancer-a longterm outcome report. Int J Radiat Oncol Biol Phys 2009;74:9-14.
23. Moeller B, Rana V, Cannon B, Williams M, Sturgis E, Ginsberg L, Macapinlac H, Lee J, Ang K, Chao K, Chronowski G, Frank S, Morrison W, Rosenthal D, Weber R, Garden A, Lippman S, Schwartz D: Prospective imaging assessment of mortality risk after head and neck radiotherapy. Int J Radiat Oncol Biol Phys 2010; 78:667-674.
24. Hatakenaka M, Nakamura K, Yabuuchi H, Shioyama Y, Matsuo Y, Ohnishi K, Sunami S, Kamitani T, Setoguchi T, Yoshiura T, Nakashima T, Nishikawa K, Honda H: Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head and neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys 2011;81:339-345.
25. Kim S, Loevner L, Quon H, Sherman E, Weinstein G, Kilger A, Poptani H: Diffusionweighted magnetic resonance imaging for predicting and detecting of early response to chemoradiation therapy of squamous cell carcinoma of the head and neck. Clin Cancer Res 2009;15:986-994.
26. Manikantan K, Khode S, Dwivedi R, Palav R, Nutting C, Rhys-Evans P, Harrington K, Kazi R: Making sense of post-treatment surveillance in head and neck cancer: When and what of followup. Cancer Treat Rev 2009;35:744-753.
27. Gambhir S, Czernin J, Schwimmer J, Silverman D, Coleman R, Phelps M: A tabulated summary of the FDG PET literature. J Nucl Med 2001;42(suppl 5):1S-93S.
28. Glastonbury C, Parker E, Hoang J: The postradiation neck: Evaluation response to treatment and recognizing complications. Am J Radiol 2010;195: W164-W171.
29. Vandecaveye V, De Keyzer F, Nuyts S, Deraedt K, Dirix P, Hamaekers P, Vander Poorten V, Delaere P, Hermans R: Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: Correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 2007;67:960-971.
30. Kyzas P, Evangelou E, Denaxa-Kyza, Ioannidis J: 18F-Fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: A meta-analysis. J Natl Cancer Inst 2008; 100:712-720.
31. Dirix P, Vandecaveye V, De Keyzer F, Stroobants S, Hermans R, Nuyts S: Dose-painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI and dynamic contrastenhanced MRI. J Nucl Med 2009;50:1020-1027.